Navigation Links
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Date:1/11/2011

ents the benefits of more rapid recovery, reduced travel costs and less time off work, allowing them to return to their normal, daily routines almost immediately as compared with the standard nine-week course of radiotherapy," said Christopher King, M.D., an author on the study who is now an Associate Professor of Radiation Oncology and Urology at the UCLA School of Medicine. "In addition, because CyberKnife radiosurgery costs less than conventional radiation and avoids the anesthesia and hospital stay associated with surgery, our national health care system benefits from reduced health care costs."

The past 12 months have seen the publication and presentation of numerous shorter term CyberKnife prostate radiosurgery experiences demonstrating encouraging outcomes.  This paper supports these outcomes within a long-term follow-up study.  Additional this month, the Accuray sponsored multi-center homogeneous prostate study for low and intermediate risk patients, led by the team at the Swedish Cancer Center in Seattle, accrued the final of 294 patients, providing a broad foundation for future long-term multi-center results.  

"The publication of five-year clinical outcomes represents a significant milestone for CyberKnife radiosurgery and is important news for physicians to consider when determining the best course of treatment for prostate cancer patients," said Euan S. Thomson, Ph.D., president and CEO of Accuray. "We look forward to this study and other multi-center studies providing additional long-term quality support of CyberKnife prostate radiosurgery outcomes."

Click here to see a patient education video about how prostate cancer is treated with the CyberKnife System.

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system de
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LUNGevity Foundation, the nation,s leading lung ... (FDA) approval of Bristol Myers Squibb,s new immunotherapy ... add another critical new treatment option to fight ... patient,s own immune system to fight cancerous cells. ... patients with squamous cell lung cancer, a population ...
(Date:3/5/2015)... , March 5, 2015 Soligenix, Inc. ... biopharmaceutical company committed to developing products that address unmet ... biodefense, announced today that its President and Chief Executive ... a corporate presentation at the 27 th Annual ... , on Tuesday, March 10, 2015 at 1:00 PM ...
(Date:3/5/2015)... , March 5, 2015 ... System Market by Product (Systems and Disposables), by Type ... Labs , Home and Ambulatory Sites) - Analysis & ... Systems Market is expected to reach $1,107.4 Million by ... to grow at a CAGR of 4.5% during the ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... Cephalon, Inc. (NASDAQ: CEPH): In a letter ... stated that it "is presently undertaking a review of ... is focused on maximizing Cephalon shareholder value."  We know ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
Cached Medicine Technology:Valeant Pharmaceuticals Responds to Cephalon Board's Letter 2Valeant Pharmaceuticals Responds to Cephalon Board's Letter 3Valeant Pharmaceuticals Responds to Cephalon Board's Letter 4Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... Knoxville, TN (PRWEB) March 06, 2015 ... on January 1, 2015, there has been an overwhelming ... implement an efficient and compliant CCM program. The ... clarification on several matters. , PYA’s updated white ... ”—incorporates this new guidance into a detailed, yet practical ...
(Date:3/6/2015)... First Choice Emergency Room opened its ... located at 13351 W. Bowles Avenue, Littleton, Colorado and is ... 24-7 to provide the highest quality emergency medical care to ... First Choice Emergency Room Littleton. , First Choice ... Denver Chamber of Commerce and a medical community open house ...
(Date:3/6/2015)... La (PRWEB) March 06, 2015 Many ... function despite medical therapy. If you (or someone you ... to knee osteoarthritis, you may be interested in the ... Covington Orthopedic announced today that he is one of ... Cytori Therapeutics to begin enrolling subjects as part of ...
(Date:3/6/2015)... Atlanta, GA (PRWEB) March 06, 2015 ... algorithms, announced the release of a Clostridium Difficile ... outpatient providers. The C Diff use case is ... capabilities that span hospital acquired infections, chronic conditions, ... phenotype platform, the C Diff solution flags at ...
Breaking Medicine News(10 mins):Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... 9 While people across the country scrutinize,the unemployed mother ... 26, eyes also must turn to the fertility doctor who ... 33-year-old mother, Nadya Suleman, the same physician,treated her for each ... that in her last IVF treatment, six embryos were transferred ...
... RoundTable Healthcare Partners,("RoundTable"), an operating-oriented private equity ... that Sandy Thompson has become a,Senior Transaction Advisor ... Thompson will,assist RoundTable in the identification of new ... Thompson has 17 years of experience in the ...
... Throughout February, Kaz, Inc., the makers of Honeywell ... "National Care About Your Indoor Air" month. ... National Parent Teacher Organization and the Healthy House ... is working to educate consumers about the importance ...
... Some patients who suffer a stroke as a result ... benefit from a clot-busting drug nine or more hours after ... online edition of Radiology . , "Stroke is ... the study,s lead author, William A. Copen, M.D., Director of ...
... Buying an outing, like going to the beach, boosts ... -- Although everyone knows that money can,t buy ... increase your well-being, new research suggests. , In a ... to rate a recent purchase intended to make them ...
... 9 The nation,s first - and only - program ... non-contact anterior cruciate ligament (ACL) tears among female high school ... in Rochester, New York. The program, called PEP ... the most serious knee injuries that can sideline athletic careers ...
Cached Medicine News:Health News:Fertility Expert Calls Birth of Octuplets 'Criminal' 2Health News:RoundTable Healthcare Partners Names Sandy Thompson as Senior Transaction Advisor 2Health News:Honeywell Home Comfort Products' Second Annual 'National Care About Your Indoor Air' Month 2Health News:Honeywell Home Comfort Products' Second Annual 'National Care About Your Indoor Air' Month 3Health News:Stroke therapy window might be extended past nine hours for some 2Health News:Experiences Bring More Joy Than Possessions Do 2Health News:Experiences Bring More Joy Than Possessions Do 3Health News:ACL Injury Prevention Program is First in Nation to Tackle Growing Problem 2Health News:ACL Injury Prevention Program is First in Nation to Tackle Growing Problem 3
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... Systems non-adhesive sealing method maintains ... Surgrery (HALS) procedures, allowing the ... palpate throughout. Because HALS requires ... cm, patients experience less trauma ...
... a Hand Assisted Laparoscopic Surgery (HALS) device ... hand may facilitate the procedure, and for ... in colorectal, urological and general surgical procedures. ... of pneumoperitoneum and abdominal access for the ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
Medicine Products: